Next, we assessed publicly available transcriptomes from IBD and colon cancer patient cohorts to determine the significance of FOXO3-deficient macrophages in human colonic inflammation and tumorigenesis. This evidence concerns the gene FOXO3 and inflammatory bowel disease.